Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses
- 8 December 2014
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 41 (4) , 398-409
Abstract
Synaptic vesicle glycoprotein (SV)2A is a transmembrane protein found in secretory vesicles and is critical for Ca2+‐dependent exocytosis in central neurons, although its mechanism of action remains uncertain. Previous studies have proposed, variously, a role of SV2 in the maintenance and formation of the readily releasable pool (RRP) or in the regulation of Ca2+ responsiveness of primed vesicles. Such previous studies have typically used genetic approaches to ablate SV2 levels; here, we used a strategy involving small interference RNA (siRNA) injection to knockdown solely presynaptic SV2A levels in rat superior cervical ganglion (SCG) neuron synapses. Moreover, we investigated the effects of SV2A knockdown on voltage‐dependent Ca2+ channel (VDCC) function in SCG neurons. Thus, we extended the studies of SV2A mechanisms by investigating the effects on vesicular transmitter release and VDCC function in peripheral sympathetic neurons. We first demonstrated an siRNA‐mediated SV2A knockdown. We showed that this SV2A knockdown markedly affected presynaptic function, causing an attenuated RRP size, increased paired‐pulse depression and delayed RRP recovery after stimulus‐dependent depletion. We further demonstrated that the SV2A–siRNA‐mediated effects on vesicular release were accompanied by a reduction in VDCC current density in isolated SCG neurons. Together, our data showed that SV2A is required for correct transmitter release at sympathetic neurons. Mechanistically, we demonstrated that presynaptic SV2A: (i) acted to direct normal synaptic transmission by maintaining RRP size, (ii) had a facilitatory role in recovery from synaptic depression, and that (iii) SV2A deficits were associated with aberrant Ca2+ current density, which may contribute to the secretory phenotype in sympathetic peripheral neurons.Keywords
Funding Information
- japan society for promotion of science
- UCB Pharma Postdoctoral Fellowship
This publication has 52 references indexed in Scilit:
- Expression of SV2 isoforms during rodent brain developmentBMC Neuroscience, 2013
- Modulation of the conformational state of theSV2Aprotein by an allosteric mechanism as evidenced by ligand binding assaysBritish Journal of Pharmacology, 2013
- Inhibition of synaptic transmission and G protein modulation by synthetic CaV2.2 Ca2+channel peptidesThe Journal of Physiology, 2011
- SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced ExocytosisThe Journal of Neuroscience, 2009
- Levetiracetam: The Profile of a Novel Anticonvulsant Drug—Part I: Preclinical DataCNS Drug Reviews, 2007
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- Synaptic Vesicle Protein 2 Enhances Release Probability at Quiescent SynapsesThe Journal of Neuroscience, 2006
- Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)Proceedings of the National Academy of Sciences, 1999
- SV2, a Brain Synaptic Vesicle Protein Homologous to Bacterial TransportersScience, 1992
- Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells.Journal of Cell Biology, 1985